Question follow-through · 3255
Infectious Disease: Health Services
To ask the Secretary of State for Health and Social Care, whether his Department has conducted an assessment of the level of public health risks associated with expedition cruise vessels visiting remote UK Overseas Territories; what protocols are in place
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 20 May 2026
- Target answer date
- 1 Jun 2026
- Answer
- 4 Jun 2026 · 15 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Ophthalmic Services: Finance · 2 Jun 2026
- Prostate Cancer: Screening · 3 Jun 2026
- Prostate Cancer: Screening · 3 Jun 2026
- Prostate Cancer: Screening · 3 Jun 2026
- Prostate Cancer: Screening · 3 Jun 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
20 May 2026
Question tabled
To ask the Secretary of State for Health and Social Care, whether his Department has conducted an assessment of the level of public health risks associated with expedition cruise vessels visiting remote UK Overseas Territories; what protocols are in place
1 Jun 2026
Target answer date
Date supplied by the official written-questions record.
4 Jun 2026
Answer published
The UK Health Security Agency (UKHSA), working closely with the Foreign, Commonwealth and Development Office and Overseas Territory governments, keeps the assessment and mitigation of public health risks associated with cruise vessels under continual revi...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Ophthalmic Services: Finance
2 Jun 2026 · To ask the Secretary of State for Health and Social Care, further to his answer on 1 June (HC Deb col 895) on the Health Bill, what safeguards he will put in place to ensure that Clauses 26-29 of Health Bill do not inadvertently (a) put General Ophthalmic
Prostate Cancer: Screening
3 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the screening policy for prostate cancer on demand on GP appointments; what additional guidance and resources will be provided to GPs to suppo
Prostate Cancer: Screening
3 Jun 2026 · To ask the Secretary of State for Health and Social Care, what estimate he has made of (a) the number of men who will be eligible for the new targeted prostate cancer screening programme, (b) the number expected to participate in screening annually, (c) t
Prostate Cancer: Screening
3 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of restricting routine screening to men with a BRCA2 gene variant and relevant family history on (a) early diagnosis rates, (b) cancer survival r
Prostate Cancer: Screening
3 Jun 2026 · To ask the Secretary of State for Health and Social Care, what estimate he has made of the cost of implementing the targeted prostate cancer screening programme; how many additional (a) PSA tests, (b) MRI scans, (c) biopsies and (d) specialist urology app
Prostate Cancer: Diagnosis
3 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made of regional variations in access to prostate cancer diagnostics and treatment; whether the new £2.8 million investment in focal therapy will be distributed across all re